#USA #San Francisco #Telehealth #ixlayer #Informed Pain Care

ixlayer Launches Informed Pain Care

ixlayer, a prominent player in cloud-based health technology, recently rolled out Informed Pain Care, an innovative digital platform aimed at enhancing access to evaluations and treatments for those suffering from acute pain. This initiative responds to the persistent challenges faced by patients who often encounter delays and fragmented healthcare experiences, particularly regarding the management of acute pain conditions.

Enhancing Patient Access

The Informed Pain Care platform serves as a bridge connecting patients with licensed healthcare professionals who can perform evaluations and suggest appropriate treatment options. The system is designed to provide access to a robust array of non-opioid treatment solutions, addressing the concerns over opioid reliance in pain management. As Pouria Sanae, the Co-founder and CEO of ixlayer, highlights: “Patients experiencing acute pain often face delays, fragmented care pathways, and limited awareness of non-opioid treatment options.” This initiative, therefore, seeks to streamline the process, providing a clinically appropriate pathway from evaluation to treatment.

Key Features

Informed Pain Care stands out with the following features that promise a high-quality telehealth experience:

• - Licensed Clinical Evaluation via Telehealth: Patients can consult with healthcare professionals from the comfort of their own homes.
• - Symptom-Based Intake and Eligibility Screening: This ensures that patients receive tailored evaluations based on their specific needs.
• - Access to Non-Opioid Treatment Options: Where clinically suitable, patients can explore a range of treatments that do not involve opioids, fostering safer alternatives.
• - Flexible Pharmacy Fulfillment: Patients can opt for local pickup or delivery of their prescriptions, enhancing convenience.
• - Insurance and Self-Pay Pathways: Implemented to ensure that cost is not a barrier to accessing necessary care.

Collaborative Approach With Vertex Pharmaceuticals

The development of this platform was in collaboration with Vertex Pharmaceuticals, emphasizing a commitment to innovation in patient care. Duncan McKechnie, Executive Vice President and Chief Commercial Officer of Vertex Pharmaceuticals, stated, “This platform provides independent telehealth evaluations for eligible nonsurgical acute pain patients, reflecting our commitment to ensuring access to innovative non-opioid medicines.”

Streamlining Healthcare

ixlayer's technology is designed to create a seamless, user-centric experience, which has already facilitated over four million patient journeys. By simplifying the complex healthcare landscape, the Informed Pain Care initiative aims to improve health equity and outcomes, making it easier for patients to receive the care they need without unnecessary delays or obstacles.

Informed Pain Care embodies the future of acute pain evaluation and management, allowing for timely and effective care within a robust digital framework. As telehealth continues to evolve, platforms like these are crucial in addressing gaps in patient care, particularly in areas where traditional healthcare access may be limited.

For more information, you can visit ixlayer's official website.